Next Article in Journal
Maintenance Therapy for Pancreatic Cancer, a New Approach Based on the Synergy between the Novel Agent GP-2250 (Misetionamide) and Gemcitabine
Next Article in Special Issue
Immunotherapy-Related Adverse Events and Clinical Outcomes in Adult Solid-Tumor Patients Admitted to an Onco-Hospitalist Medicine Service
Previous Article in Journal
Alectinib in Early-Stage Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer: Current Evidence and Future Challenges
Previous Article in Special Issue
Outcomes and Adverse Events in Patients with Cancer after Diagnosis of Immunotherapy-Associated Diabetes Mellitus: A Retrospective Cohort Study
 
 
Article

Article Versions Notes

Cancers 2024, 16(14), 2611; https://doi.org/10.3390/cancers16142611
Action Date Notes Link
article pdf uploaded. 22 July 2024 16:10 CEST Version of Record https://www.mdpi.com/2072-6694/16/14/2611/pdf-vor
article supplementary file uploaded. 22 July 2024 16:10 CEST - https://www.mdpi.com/2072-6694/16/14/2611#supplementary
article pdf uploaded. 22 July 2024 17:15 CEST Updated version of record https://www.mdpi.com/2072-6694/16/14/2611/pdf-vor
article xml file uploaded 23 July 2024 11:09 CEST Original file -
article xml uploaded. 23 July 2024 11:09 CEST Update https://www.mdpi.com/2072-6694/16/14/2611/xml
article pdf uploaded. 23 July 2024 11:09 CEST Updated version of record https://www.mdpi.com/2072-6694/16/14/2611/pdf
article html file updated 23 July 2024 11:11 CEST Original file https://www.mdpi.com/2072-6694/16/14/2611/html
Back to TopTop